Renescience A/S: Financial statements 2015
CVR: 31846803
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Renescience A/S (CVR 31846803) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -55,972,000 and a net result of DKK -43,214,000 compared with DKK -19,400,000 the year before. Equity in the 2015 report amounted to DKK 24,066,000. The solvency ratio was 69%.
- Gross Profit
- DKK -55,972,000
- Profit/Loss
- DKK -43,214,000
- Equity
- DKK 24,066,000
- Total Assets
- DKK 34,898,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -56 mio. | -43.2 mio. | 24.1 mio. | - |
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
| 2012 | - | -21 mio. | -16.6 mio. | 17.6 mio. | - |
Official annual report
How creditworthy is Renescience A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of October 9, 2015, Anna-Lena Elisabet Jeppsson is registered as director of Renescience A/S.
As of October 9, 2015, Henrik Maimann has stepped down as director of Renescience A/S.
Renescience A/S has published its annual report for 2014. Gross profit came to DKK -26,446,000, and the net result was DKK -19,400,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.